Further understanding the molecular basis of FGF10 transcriptional regulation in normal and disease states could identify new treatment strategies for BPD and other clinical scenarios where maintaining FGF10 expression could provide benefit. Here, FGF10 is linked to bronchopulmonary dysplasia.